Quantification and Localisation of New Brain Lipid Synthesis Using Deuterium Oxide and High Resolution Mass Spectrometry
Angewandte Chemie International Edition · 2026
DOI: 10.1002/anie.202524636 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Catherine Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences, Charles Perkins Centre, and Brain and Mind Centre, The University of Sydney, Camperdown, New South Wales, Australia. Hauptthemen laut MEDLINE: Deuterium Oxide, Brain, Lipids. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council of Australia, Multiple Sclerosis Australia, Australian government Research Training Program scholarship.
Abstract (Originalsprache)
Myelin is the lipid‐rich membrane that surrounds neuronal axons and is essential for neurological function in vertebrates. The development of therapeutics that stimulate myelin repair to treat demyelinating disorders such as multiple sclerosis is hampered by the inability to distinguish newly synthesised from pre‐existing myelin. This study aimed to develop a method to quantify and localise new myelin lipid synthesis in the mouse brain. Deuterium oxide was administered for two weeks in the drinking water of mice fed normal chow, chow containing the demyelinating toxin cuprizone, or during spontaneous remyelination following cuprizone withdrawal. Liquid chromatography‐tandem mass spectrometry and mass spectrometry imaging were used to quantify and localise the newly synthesised, deuterated lipids. While most glycerophospholipids were constitutively deuterated, deuteration of myelin‐enriched sulfatides, hexosylceramides, and phosphatidylethanolamine plasmalogens was only apparent during remyelination. Most deuterium atoms were found in the fatty acyl chains, indicative of de novo lipid synthesis. Deuterated hexosylceramide and phosphatidylethanolamine plasmalogen species were localised primarily to the corpus callosum, the white matter tract that is most heavily affected by cuprizone. The method described herein provides the means to quantify and spatially profile dynamic lipid synthesis across diverse biological contexts, including understanding myelin homeostasis and preclinical evaluation of remyelinating therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Sciences, Charles Perkins Centre, and Brain and Mind Centre, The University of Sydney, Camperdown, New South Wales, Australia.
- Molecular Horizons and School of Science, The University of Wollongong, Wollongong, New South Wales, Australia.
ORCID-Profile: Anthony S Don
Förderung
- National Health and Medical Research Council of Australia
- Multiple Sclerosis Australia
- Australian government Research Training Program scholarship
- Australian Research Council Future Fellowship
Zitieren
APA
Zhang, C., Michael, J. A., Teo, J. D., Song, H., Westerhausen, M. T., Mutuku, S. M., Ellis, S. R., & Don, A. S. (2026). Quantification and Localisation of New Brain Lipid Synthesis Using Deuterium Oxide and High Resolution Mass Spectrometry. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202524636
Vancouver
Zhang C, Michael JA, Teo JD, Song H, Westerhausen MT, Mutuku SM, et al. Quantification and Localisation of New Brain Lipid Synthesis Using Deuterium Oxide and High Resolution Mass Spectrometry. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.202524636
BibTeX
@article{Zhang2026,
author = {Zhang, Catherine and Michael, Jesse A and Teo, Jonathan D and Song, Huitong and Westerhausen, Mika T and Mutuku, Shadrack M and Ellis, Shane R and Don, Anthony S},
title = {Quantification and Localisation of New Brain Lipid Synthesis Using Deuterium Oxide and High Resolution Mass Spectrometry},
journal = {Angewandte Chemie International Edition},
year = {2026},
doi = {10.1002/anie.202524636}
}
EUVIMED